Gio’s Law
Epinephrine Access and Training for Law Enforcement
Gio’s Law is currently in the early stages of the legislative process. It was recently sent to the House Committee on the Judiciary for review. The bill is actively moving forward, but no future votes have been scheduled yet.
Legislative Progress
This bill has support from both parties and addresses a clear safety need, but it is still in the very early stages of the lawmaking process.
Key Points
- This bill creates a new grant program to help local, state, and tribal police departments buy epinephrine products like EpiPens. It also pays for training so officers can recognize when someone is having a severe allergic reaction and know how to give the medicine safely.
- Police officers would be the first ones to use this medicine during emergencies before an ambulance arrives. To get the money, states must prove that their laws protect officers from being sued if they try to help someone in good faith.
- Severe allergic reactions can be fatal in minutes, and police are often the first people to arrive at an emergency. Giving them the tools to treat these reactions could save lives in communities where medical help is far away.
- The bill would set aside $25 million every year from 2026 to 2030. It also requires the government to track how often police use this medicine and run a public campaign to teach people about allergy symptoms.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Referred to the House Committee on the Judiciary.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Gio’s Law
Data Sources
Sponsor
Cosponsors
(7)Analysis generated by AI. Always verify with official sources.